nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—colon cancer	0.32	1	CbGbCtD
Niacin—QPRT—renal system—colon cancer	0.023	0.101	CbGeAlD
Niacin—NNMT—gall bladder—colon cancer	0.0226	0.0988	CbGeAlD
Niacin—HCAR2—lymphoid tissue—colon cancer	0.016	0.07	CbGeAlD
Niacin—QPRT—liver—colon cancer	0.0141	0.0615	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—CHST4—colon cancer	0.0126	0.186	CbGpPWpGaD
Niacin—NNMT—smooth muscle tissue—colon cancer	0.0113	0.0493	CbGeAlD
Niacin—NNMT—renal system—colon cancer	0.0108	0.0474	CbGeAlD
Niacin—HCAR2—lymph node—colon cancer	0.00903	0.0395	CbGeAlD
Niacin—NNMT—digestive system—colon cancer	0.0089	0.0389	CbGeAlD
Niacin—QPRT—Nicotinate metabolism—PTGS2—colon cancer	0.00822	0.121	CbGpPWpGaD
Niacin—NNMT—bone marrow—colon cancer	0.0082	0.0359	CbGeAlD
Niacin—SLC16A3—epithelium—colon cancer	0.00799	0.0349	CbGeAlD
Niacin—NNMT—vagina—colon cancer	0.00786	0.0343	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—colon cancer	0.0077	0.0336	CbGeAlD
Niacin—SLC16A3—renal system—colon cancer	0.00741	0.0324	CbGeAlD
Niacin—NNMT—liver—colon cancer	0.00663	0.029	CbGeAlD
Niacin—SLC16A3—digestive system—colon cancer	0.00608	0.0266	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—CHST5—colon cancer	0.00577	0.0853	CbGpPWpGaD
Niacin—SLC16A3—bone marrow—colon cancer	0.0056	0.0245	CbGeAlD
Niacin—NNMT—lymph node—colon cancer	0.00508	0.0222	CbGeAlD
Niacin—SLC16A1—epithelium—colon cancer	0.00485	0.0212	CbGeAlD
Niacin—SLC16A3—liver—colon cancer	0.00453	0.0198	CbGeAlD
Niacin—SLC16A1—renal system—colon cancer	0.0045	0.0197	CbGeAlD
Niacin—SLCO2B1—renal system—colon cancer	0.00387	0.0169	CbGeAlD
Niacin—SLC16A1—digestive system—colon cancer	0.00369	0.0161	CbGeAlD
Niacin—SLC16A3—lymph node—colon cancer	0.00347	0.0152	CbGeAlD
Niacin—SLCO2B1—digestive system—colon cancer	0.00318	0.0139	CbGeAlD
Niacin—SLC16A1—liver—colon cancer	0.00275	0.012	CbGeAlD
Niacin—SLC22A5—renal system—colon cancer	0.00257	0.0112	CbGeAlD
Niacin—SLCO2B1—liver—colon cancer	0.00237	0.0103	CbGeAlD
Niacin—SLC22A5—digestive system—colon cancer	0.00211	0.00922	CbGeAlD
Niacin—SLC16A1—lymph node—colon cancer	0.00211	0.00922	CbGeAlD
Niacin—SLC22A5—vagina—colon cancer	0.00186	0.00814	CbGeAlD
Niacin—SLCO2B1—lymph node—colon cancer	0.00181	0.00793	CbGeAlD
Niacin—QPRT—Metabolism—CA7—colon cancer	0.00178	0.0263	CbGpPWpGaD
Niacin—Salicylic acid—PTGS2—colon cancer	0.00173	0.54	CrCbGaD
Niacin—CYP2D6—renal system—colon cancer	0.00166	0.00725	CbGeAlD
Niacin—NNMT—Metabolism—CA7—colon cancer	0.00165	0.0244	CbGpPWpGaD
Niacin—SLC22A5—liver—colon cancer	0.00157	0.00687	CbGeAlD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.00157	0.0232	CbGpPWpGaD
Niacin—Salicylic acid—ABCB1—colon cancer	0.00147	0.46	CrCbGaD
Niacin—Polyuria—Capecitabine—colon cancer	0.00142	0.00373	CcSEcCtD
Niacin—Skin discolouration—Methotrexate—colon cancer	0.00141	0.00372	CcSEcCtD
Niacin—Bone disorder—Methotrexate—colon cancer	0.00141	0.00372	CcSEcCtD
Niacin—Sweating—Vincristine—colon cancer	0.00141	0.00371	CcSEcCtD
Niacin—Hyperbilirubinaemia—Methotrexate—colon cancer	0.0014	0.00369	CcSEcCtD
Niacin—Stomatitis—Irinotecan—colon cancer	0.0014	0.00367	CcSEcCtD
Niacin—Jaundice—Irinotecan—colon cancer	0.0014	0.00367	CcSEcCtD
Niacin—Hyperuricaemia—Methotrexate—colon cancer	0.00138	0.00362	CcSEcCtD
Niacin—Sweating—Irinotecan—colon cancer	0.00137	0.00361	CcSEcCtD
Niacin—CYP2D6—digestive system—colon cancer	0.00136	0.00595	CbGeAlD
Niacin—Stomatitis—Fluorouracil—colon cancer	0.00134	0.00352	CcSEcCtD
Niacin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00132	0.0195	CbGpPWpGaD
Niacin—Hypoaesthesia—Vincristine—colon cancer	0.00131	0.00346	CcSEcCtD
Niacin—Atrial fibrillation—Capecitabine—colon cancer	0.00131	0.00345	CcSEcCtD
Niacin—Dermatitis bullous—Capecitabine—colon cancer	0.0013	0.00342	CcSEcCtD
Niacin—Blood uric acid increased—Methotrexate—colon cancer	0.0013	0.00342	CcSEcCtD
Niacin—Haemoglobin—Irinotecan—colon cancer	0.00129	0.0034	CcSEcCtD
Niacin—Rhinitis—Irinotecan—colon cancer	0.00129	0.00339	CcSEcCtD
Niacin—QPRT—Disease—LGR5—colon cancer	0.00129	0.019	CbGpPWpGaD
Niacin—QPRT—Disease—CHST5—colon cancer	0.00129	0.019	CbGpPWpGaD
Niacin—Haemorrhage—Irinotecan—colon cancer	0.00129	0.00338	CcSEcCtD
Niacin—Arthritis—Capecitabine—colon cancer	0.00128	0.00337	CcSEcCtD
Niacin—Vaginal inflammation—Methotrexate—colon cancer	0.00128	0.00336	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00124	0.00327	CcSEcCtD
Niacin—Visual impairment—Irinotecan—colon cancer	0.00124	0.00326	CcSEcCtD
Niacin—Haemoglobin—Fluorouracil—colon cancer	0.00124	0.00326	CcSEcCtD
Niacin—Rhinitis—Fluorouracil—colon cancer	0.00123	0.00325	CcSEcCtD
Niacin—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00123	0.00325	CcSEcCtD
Niacin—Haemorrhage—Fluorouracil—colon cancer	0.00123	0.00324	CcSEcCtD
Niacin—Hypoaesthesia—Fluorouracil—colon cancer	0.00123	0.00322	CcSEcCtD
Niacin—Migraine—Capecitabine—colon cancer	0.00122	0.00322	CcSEcCtD
Niacin—Skin exfoliation—Methotrexate—colon cancer	0.00122	0.0032	CcSEcCtD
Niacin—SLC22A5—lymph node—colon cancer	0.0012	0.00527	CbGeAlD
Niacin—Vaginal infection—Methotrexate—colon cancer	0.0012	0.00317	CcSEcCtD
Niacin—Face oedema—Capecitabine—colon cancer	0.0012	0.00316	CcSEcCtD
Niacin—Angiopathy—Vincristine—colon cancer	0.0012	0.00315	CcSEcCtD
Niacin—Flushing—Irinotecan—colon cancer	0.00119	0.00314	CcSEcCtD
Niacin—Urinary retention—Capecitabine—colon cancer	0.00118	0.00311	CcSEcCtD
Niacin—Alopecia—Vincristine—colon cancer	0.00117	0.00307	CcSEcCtD
Niacin—Angiopathy—Irinotecan—colon cancer	0.00117	0.00307	CcSEcCtD
Niacin—Chills—Irinotecan—colon cancer	0.00115	0.00304	CcSEcCtD
Niacin—Urine output increased—Methotrexate—colon cancer	0.00115	0.00303	CcSEcCtD
Niacin—Arrhythmia—Irinotecan—colon cancer	0.00115	0.00302	CcSEcCtD
Niacin—Liver function test abnormal—Capecitabine—colon cancer	0.00115	0.00302	CcSEcCtD
Niacin—Dry skin—Capecitabine—colon cancer	0.00114	0.003	CcSEcCtD
Niacin—Alopecia—Irinotecan—colon cancer	0.00114	0.00299	CcSEcCtD
Niacin—Orthostatic hypotension—Capecitabine—colon cancer	0.00114	0.00299	CcSEcCtD
Niacin—Flatulence—Irinotecan—colon cancer	0.0011	0.0029	CcSEcCtD
Niacin—Arrhythmia—Fluorouracil—colon cancer	0.0011	0.00289	CcSEcCtD
Niacin—Muscular weakness—Capecitabine—colon cancer	0.0011	0.00289	CcSEcCtD
Niacin—Alopecia—Fluorouracil—colon cancer	0.00109	0.00286	CcSEcCtD
Niacin—Abdominal distension—Capecitabine—colon cancer	0.00108	0.00285	CcSEcCtD
Niacin—QPRT—Metabolism—ODC1—colon cancer	0.00108	0.0159	CbGpPWpGaD
Niacin—QPRT—Metabolism—CHST5—colon cancer	0.00108	0.0159	CbGpPWpGaD
Niacin—Muscle spasms—Irinotecan—colon cancer	0.00108	0.00283	CcSEcCtD
Niacin—Dysphagia—Capecitabine—colon cancer	0.00108	0.00283	CcSEcCtD
Niacin—Influenza—Capecitabine—colon cancer	0.00108	0.00283	CcSEcCtD
Niacin—Erythema—Fluorouracil—colon cancer	0.00107	0.00282	CcSEcCtD
Niacin—Diabetes mellitus—Methotrexate—colon cancer	0.00106	0.0028	CcSEcCtD
Niacin—Polyuria—Methotrexate—colon cancer	0.00105	0.00277	CcSEcCtD
Niacin—Angina pectoris—Capecitabine—colon cancer	0.00105	0.00276	CcSEcCtD
Niacin—Bronchitis—Capecitabine—colon cancer	0.00103	0.00272	CcSEcCtD
Niacin—Vertigo—Vincristine—colon cancer	0.00103	0.00272	CcSEcCtD
Niacin—Leukopenia—Vincristine—colon cancer	0.00103	0.00271	CcSEcCtD
Niacin—CYP2D6—liver—colon cancer	0.00101	0.00443	CbGeAlD
Niacin—Vision blurred—Fluorouracil—colon cancer	0.00101	0.00266	CcSEcCtD
Niacin—Vertigo—Irinotecan—colon cancer	0.00101	0.00265	CcSEcCtD
Niacin—Syncope—Irinotecan—colon cancer	0.001	0.00264	CcSEcCtD
Niacin—Leukopenia—Irinotecan—colon cancer	0.001	0.00264	CcSEcCtD
Niacin—NNMT—Metabolism—ODC1—colon cancer	0.001	0.0148	CbGpPWpGaD
Niacin—NNMT—Metabolism—CHST5—colon cancer	0.001	0.0148	CbGpPWpGaD
Niacin—Loss of consciousness—Irinotecan—colon cancer	0.000984	0.00259	CcSEcCtD
Niacin—Myalgia—Vincristine—colon cancer	0.000978	0.00257	CcSEcCtD
Niacin—Cough—Irinotecan—colon cancer	0.000977	0.00257	CcSEcCtD
Niacin—Leukopenia—Fluorouracil—colon cancer	0.00096	0.00252	CcSEcCtD
Niacin—Anaphylactic shock—Vincristine—colon cancer	0.000938	0.00247	CcSEcCtD
Niacin—Oedema—Vincristine—colon cancer	0.000938	0.00247	CcSEcCtD
Niacin—Jaundice—Capecitabine—colon cancer	0.000934	0.00246	CcSEcCtD
Niacin—Stomatitis—Capecitabine—colon cancer	0.000934	0.00246	CcSEcCtD
Niacin—QPRT—Disease—AXIN2—colon cancer	0.000924	0.0136	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.000924	0.0136	CbGpPWpGaD
Niacin—Anaphylactic shock—Irinotecan—colon cancer	0.000913	0.0024	CcSEcCtD
Niacin—Oedema—Irinotecan—colon cancer	0.000913	0.0024	CcSEcCtD
Niacin—Myalgia—Fluorouracil—colon cancer	0.000913	0.0024	CcSEcCtD
Niacin—Hyperhidrosis—Vincristine—colon cancer	0.000907	0.00239	CcSEcCtD
Niacin—Shock—Irinotecan—colon cancer	0.000899	0.00236	CcSEcCtD
Niacin—Anorexia—Vincristine—colon cancer	0.000894	0.00235	CcSEcCtD
Niacin—Hyperhidrosis—Irinotecan—colon cancer	0.000883	0.00232	CcSEcCtD
Niacin—Hypotension—Vincristine—colon cancer	0.000876	0.00231	CcSEcCtD
Niacin—Oedema—Fluorouracil—colon cancer	0.000875	0.0023	CcSEcCtD
Niacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000875	0.0023	CcSEcCtD
Niacin—Anorexia—Irinotecan—colon cancer	0.000871	0.00229	CcSEcCtD
Niacin—Haemoglobin—Capecitabine—colon cancer	0.000865	0.00228	CcSEcCtD
Niacin—Rhinitis—Capecitabine—colon cancer	0.000863	0.00227	CcSEcCtD
Niacin—Hepatitis—Capecitabine—colon cancer	0.00086	0.00226	CcSEcCtD
Niacin—Haemorrhage—Capecitabine—colon cancer	0.00086	0.00226	CcSEcCtD
Niacin—Hypoaesthesia—Capecitabine—colon cancer	0.000856	0.00225	CcSEcCtD
Niacin—Liver function test abnormal—Methotrexate—colon cancer	0.000855	0.00225	CcSEcCtD
Niacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000855	0.00225	CcSEcCtD
Niacin—Tachycardia—Fluorouracil—colon cancer	0.000854	0.00225	CcSEcCtD
Niacin—Hypotension—Irinotecan—colon cancer	0.000854	0.00225	CcSEcCtD
Niacin—Insomnia—Vincristine—colon cancer	0.000848	0.00223	CcSEcCtD
Niacin—Oedema peripheral—Capecitabine—colon cancer	0.000848	0.00223	CcSEcCtD
Niacin—Paraesthesia—Vincristine—colon cancer	0.000842	0.00222	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—DLC1—colon cancer	0.000837	0.0124	CbGpPWpGaD
Niacin—Anorexia—Fluorouracil—colon cancer	0.000834	0.00219	CcSEcCtD
Niacin—Visual impairment—Capecitabine—colon cancer	0.000829	0.00218	CcSEcCtD
Niacin—Insomnia—Irinotecan—colon cancer	0.000826	0.00217	CcSEcCtD
Niacin—Paraesthesia—Irinotecan—colon cancer	0.00082	0.00216	CcSEcCtD
Niacin—Hypotension—Fluorouracil—colon cancer	0.000817	0.00215	CcSEcCtD
Niacin—Decreased appetite—Vincristine—colon cancer	0.000815	0.00215	CcSEcCtD
Niacin—Dyspnoea—Irinotecan—colon cancer	0.000814	0.00214	CcSEcCtD
Niacin—Somnolence—Irinotecan—colon cancer	0.000812	0.00214	CcSEcCtD
Niacin—Gastrointestinal disorder—Vincristine—colon cancer	0.00081	0.00213	CcSEcCtD
Niacin—SLC16A3—Metabolism—CA7—colon cancer	0.000807	0.0119	CbGpPWpGaD
Niacin—Eye disorder—Capecitabine—colon cancer	0.000804	0.00212	CcSEcCtD
Niacin—Dyspepsia—Irinotecan—colon cancer	0.000804	0.00212	CcSEcCtD
Niacin—Tinnitus—Capecitabine—colon cancer	0.000802	0.00211	CcSEcCtD
Niacin—Pain—Vincristine—colon cancer	0.000802	0.00211	CcSEcCtD
Niacin—Flushing—Capecitabine—colon cancer	0.000799	0.0021	CcSEcCtD
Niacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000797	0.0021	CcSEcCtD
Niacin—Decreased appetite—Irinotecan—colon cancer	0.000794	0.00209	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—DLC1—colon cancer	0.000794	0.0117	CbGpPWpGaD
Niacin—Insomnia—Fluorouracil—colon cancer	0.000791	0.00208	CcSEcCtD
Niacin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000789	0.00207	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—LGR5—colon cancer	0.000787	0.0116	CbGpPWpGaD
Niacin—Paraesthesia—Fluorouracil—colon cancer	0.000786	0.00207	CcSEcCtD
Niacin—Pain—Irinotecan—colon cancer	0.000781	0.00206	CcSEcCtD
Niacin—Angiopathy—Capecitabine—colon cancer	0.000781	0.00205	CcSEcCtD
Niacin—Dyspnoea—Fluorouracil—colon cancer	0.00078	0.00205	CcSEcCtD
Niacin—Somnolence—Fluorouracil—colon cancer	0.000778	0.00205	CcSEcCtD
Niacin—Chills—Capecitabine—colon cancer	0.000772	0.00203	CcSEcCtD
Niacin—Dyspepsia—Fluorouracil—colon cancer	0.00077	0.00203	CcSEcCtD
Niacin—Arrhythmia—Capecitabine—colon cancer	0.000769	0.00202	CcSEcCtD
Niacin—Gastrointestinal pain—Vincristine—colon cancer	0.000767	0.00202	CcSEcCtD
Niacin—Decreased appetite—Fluorouracil—colon cancer	0.00076	0.002	CcSEcCtD
Niacin—Alopecia—Capecitabine—colon cancer	0.00076	0.002	CcSEcCtD
Niacin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000755	0.00199	CcSEcCtD
Niacin—Erythema—Capecitabine—colon cancer	0.000749	0.00197	CcSEcCtD
Niacin—Malnutrition—Capecitabine—colon cancer	0.000749	0.00197	CcSEcCtD
Niacin—Pain—Fluorouracil—colon cancer	0.000748	0.00197	CcSEcCtD
Niacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000747	0.00197	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—LGR5—colon cancer	0.000746	0.011	CbGpPWpGaD
Niacin—Body temperature increased—Vincristine—colon cancer	0.000741	0.00195	CcSEcCtD
Niacin—Abdominal pain—Vincristine—colon cancer	0.000741	0.00195	CcSEcCtD
Niacin—Flatulence—Capecitabine—colon cancer	0.000738	0.00194	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—colon cancer	0.000737	0.00194	CcSEcCtD
Niacin—Body temperature increased—Irinotecan—colon cancer	0.000722	0.0019	CcSEcCtD
Niacin—Abdominal pain—Irinotecan—colon cancer	0.000722	0.0019	CcSEcCtD
Niacin—Muscle spasms—Capecitabine—colon cancer	0.00072	0.00189	CcSEcCtD
Niacin—Vision blurred—Capecitabine—colon cancer	0.000706	0.00186	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—TGFB1—colon cancer	0.000698	0.0103	CbGpPWpGaD
Niacin—Stomatitis—Methotrexate—colon cancer	0.000696	0.00183	CcSEcCtD
Niacin—Urticaria—Fluorouracil—colon cancer	0.000695	0.00183	CcSEcCtD
Niacin—Body temperature increased—Fluorouracil—colon cancer	0.000692	0.00182	CcSEcCtD
Niacin—Hypersensitivity—Vincristine—colon cancer	0.000691	0.00182	CcSEcCtD
Niacin—Sweating—Methotrexate—colon cancer	0.000684	0.0018	CcSEcCtD
Niacin—Vertigo—Capecitabine—colon cancer	0.000673	0.00177	CcSEcCtD
Niacin—Hypersensitivity—Irinotecan—colon cancer	0.000673	0.00177	CcSEcCtD
Niacin—Asthenia—Vincristine—colon cancer	0.000673	0.00177	CcSEcCtD
Niacin—Syncope—Capecitabine—colon cancer	0.000672	0.00177	CcSEcCtD
Niacin—Leukopenia—Capecitabine—colon cancer	0.000671	0.00176	CcSEcCtD
Niacin—Palpitations—Capecitabine—colon cancer	0.000662	0.00174	CcSEcCtD
Niacin—Loss of consciousness—Capecitabine—colon cancer	0.000658	0.00173	CcSEcCtD
Niacin—Asthenia—Irinotecan—colon cancer	0.000655	0.00172	CcSEcCtD
Niacin—Cough—Capecitabine—colon cancer	0.000654	0.00172	CcSEcCtD
Niacin—Hypersensitivity—Fluorouracil—colon cancer	0.000645	0.0017	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—colon cancer	0.000644	0.00169	CcSEcCtD
Niacin—Diarrhoea—Vincristine—colon cancer	0.000642	0.00169	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—colon cancer	0.000641	0.00169	CcSEcCtD
Niacin—Hepatitis—Methotrexate—colon cancer	0.000641	0.00169	CcSEcCtD
Niacin—Arthralgia—Capecitabine—colon cancer	0.000638	0.00168	CcSEcCtD
Niacin—Myalgia—Capecitabine—colon cancer	0.000638	0.00168	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000633	0.00167	CcSEcCtD
Niacin—Diarrhoea—Irinotecan—colon cancer	0.000625	0.00164	CcSEcCtD
Niacin—Dry mouth—Capecitabine—colon cancer	0.000624	0.00164	CcSEcCtD
Niacin—Dizziness—Vincristine—colon cancer	0.00062	0.00163	CcSEcCtD
Niacin—Pruritus—Fluorouracil—colon cancer	0.000619	0.00163	CcSEcCtD
Niacin—Visual impairment—Methotrexate—colon cancer	0.000617	0.00162	CcSEcCtD
Niacin—Oedema—Capecitabine—colon cancer	0.000611	0.00161	CcSEcCtD
Niacin—Dizziness—Irinotecan—colon cancer	0.000604	0.00159	CcSEcCtD
Niacin—Shock—Capecitabine—colon cancer	0.000601	0.00158	CcSEcCtD
Niacin—Eye disorder—Methotrexate—colon cancer	0.000599	0.00158	CcSEcCtD
Niacin—Diarrhoea—Fluorouracil—colon cancer	0.000599	0.00158	CcSEcCtD
Niacin—Tinnitus—Methotrexate—colon cancer	0.000597	0.00157	CcSEcCtD
Niacin—Tachycardia—Capecitabine—colon cancer	0.000597	0.00157	CcSEcCtD
Niacin—Vomiting—Vincristine—colon cancer	0.000596	0.00157	CcSEcCtD
Niacin—Skin disorder—Capecitabine—colon cancer	0.000594	0.00156	CcSEcCtD
Niacin—Rash—Vincristine—colon cancer	0.000591	0.00156	CcSEcCtD
Niacin—Hyperhidrosis—Capecitabine—colon cancer	0.000591	0.00156	CcSEcCtD
Niacin—Dermatitis—Vincristine—colon cancer	0.000591	0.00155	CcSEcCtD
Niacin—Headache—Vincristine—colon cancer	0.000588	0.00155	CcSEcCtD
Niacin—Anorexia—Capecitabine—colon cancer	0.000583	0.00153	CcSEcCtD
Niacin—Angiopathy—Methotrexate—colon cancer	0.000581	0.00153	CcSEcCtD
Niacin—Vomiting—Irinotecan—colon cancer	0.000581	0.00153	CcSEcCtD
Niacin—Dizziness—Fluorouracil—colon cancer	0.000579	0.00152	CcSEcCtD
Niacin—Rash—Irinotecan—colon cancer	0.000576	0.00152	CcSEcCtD
Niacin—Dermatitis—Irinotecan—colon cancer	0.000575	0.00151	CcSEcCtD
Niacin—Chills—Methotrexate—colon cancer	0.000575	0.00151	CcSEcCtD
Niacin—Headache—Irinotecan—colon cancer	0.000572	0.00151	CcSEcCtD
Niacin—Hypotension—Capecitabine—colon cancer	0.000571	0.0015	CcSEcCtD
Niacin—Alopecia—Methotrexate—colon cancer	0.000566	0.00149	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—AXIN2—colon cancer	0.000565	0.00835	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000565	0.00835	CbGpPWpGaD
Niacin—Malnutrition—Methotrexate—colon cancer	0.000558	0.00147	CcSEcCtD
Niacin—Erythema—Methotrexate—colon cancer	0.000558	0.00147	CcSEcCtD
Niacin—Nausea—Vincristine—colon cancer	0.000557	0.00147	CcSEcCtD
Niacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000557	0.00147	CcSEcCtD
Niacin—Vomiting—Fluorouracil—colon cancer	0.000556	0.00146	CcSEcCtD
Niacin—Insomnia—Capecitabine—colon cancer	0.000553	0.00145	CcSEcCtD
Niacin—Rash—Fluorouracil—colon cancer	0.000552	0.00145	CcSEcCtD
Niacin—Dermatitis—Fluorouracil—colon cancer	0.000551	0.00145	CcSEcCtD
Niacin—Paraesthesia—Capecitabine—colon cancer	0.000549	0.00144	CcSEcCtD
Niacin—Headache—Fluorouracil—colon cancer	0.000548	0.00144	CcSEcCtD
Niacin—Dyspnoea—Capecitabine—colon cancer	0.000545	0.00143	CcSEcCtD
Niacin—Nausea—Irinotecan—colon cancer	0.000543	0.00143	CcSEcCtD
Niacin—Dyspepsia—Capecitabine—colon cancer	0.000538	0.00142	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AXIN2—colon cancer	0.000536	0.00792	CbGpPWpGaD
Niacin—Decreased appetite—Capecitabine—colon cancer	0.000531	0.0014	CcSEcCtD
Niacin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000528	0.00139	CcSEcCtD
Niacin—Vision blurred—Methotrexate—colon cancer	0.000526	0.00138	CcSEcCtD
Niacin—Pain—Capecitabine—colon cancer	0.000523	0.00138	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—SRC—colon cancer	0.00052	0.00769	CbGpPWpGaD
Niacin—Nausea—Fluorouracil—colon cancer	0.00052	0.00137	CcSEcCtD
Niacin—Vertigo—Methotrexate—colon cancer	0.000501	0.00132	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.0005	0.00739	CbGpPWpGaD
Niacin—Gastrointestinal pain—Capecitabine—colon cancer	0.0005	0.00132	CcSEcCtD
Niacin—Leukopenia—Methotrexate—colon cancer	0.000499	0.00131	CcSEcCtD
Niacin—SLC16A3—Metabolism—ODC1—colon cancer	0.000489	0.00722	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CHST5—colon cancer	0.000489	0.00722	CbGpPWpGaD
Niacin—Cough—Methotrexate—colon cancer	0.000487	0.00128	CcSEcCtD
Niacin—Urticaria—Capecitabine—colon cancer	0.000486	0.00128	CcSEcCtD
Niacin—Body temperature increased—Capecitabine—colon cancer	0.000483	0.00127	CcSEcCtD
Niacin—Abdominal pain—Capecitabine—colon cancer	0.000483	0.00127	CcSEcCtD
Niacin—Arthralgia—Methotrexate—colon cancer	0.000475	0.00125	CcSEcCtD
Niacin—Myalgia—Methotrexate—colon cancer	0.000475	0.00125	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000471	0.00124	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—colon cancer	0.000455	0.0012	CcSEcCtD
Niacin—Hypersensitivity—Capecitabine—colon cancer	0.00045	0.00119	CcSEcCtD
Niacin—Skin disorder—Methotrexate—colon cancer	0.000442	0.00116	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—colon cancer	0.00044	0.00116	CcSEcCtD
Niacin—Asthenia—Capecitabine—colon cancer	0.000439	0.00115	CcSEcCtD
Niacin—SLC16A1—Metabolism—CA7—colon cancer	0.000436	0.00644	CbGpPWpGaD
Niacin—Anorexia—Methotrexate—colon cancer	0.000434	0.00114	CcSEcCtD
Niacin—Pruritus—Capecitabine—colon cancer	0.000433	0.00114	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.000431	0.00636	CbGpPWpGaD
Niacin—Hypotension—Methotrexate—colon cancer	0.000425	0.00112	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000424	0.00627	CbGpPWpGaD
Niacin—Diarrhoea—Capecitabine—colon cancer	0.000418	0.0011	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000415	0.00109	CcSEcCtD
Niacin—Insomnia—Methotrexate—colon cancer	0.000412	0.00108	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—colon cancer	0.000409	0.00108	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—colon cancer	0.000406	0.00107	CcSEcCtD
Niacin—Somnolence—Methotrexate—colon cancer	0.000405	0.00106	CcSEcCtD
Niacin—Dizziness—Capecitabine—colon cancer	0.000404	0.00106	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—colon cancer	0.000401	0.00105	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000396	0.00585	CbGpPWpGaD
Niacin—Decreased appetite—Methotrexate—colon cancer	0.000396	0.00104	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000393	0.00103	CcSEcCtD
Niacin—Pain—Methotrexate—colon cancer	0.000389	0.00102	CcSEcCtD
Niacin—Vomiting—Capecitabine—colon cancer	0.000389	0.00102	CcSEcCtD
Niacin—Rash—Capecitabine—colon cancer	0.000385	0.00101	CcSEcCtD
Niacin—Dermatitis—Capecitabine—colon cancer	0.000385	0.00101	CcSEcCtD
Niacin—Headache—Capecitabine—colon cancer	0.000383	0.00101	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—colon cancer	0.000372	0.000979	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.000366	0.00541	CbGpPWpGaD
Niacin—Nausea—Capecitabine—colon cancer	0.000363	0.000955	CcSEcCtD
Niacin—Urticaria—Methotrexate—colon cancer	0.000362	0.000951	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—colon cancer	0.00036	0.000947	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—colon cancer	0.00036	0.000947	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—colon cancer	0.000335	0.000882	CcSEcCtD
Niacin—Asthenia—Methotrexate—colon cancer	0.000327	0.000859	CcSEcCtD
Niacin—Pruritus—Methotrexate—colon cancer	0.000322	0.000847	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—colon cancer	0.000311	0.000819	CcSEcCtD
Niacin—Dizziness—Methotrexate—colon cancer	0.000301	0.000792	CcSEcCtD
Niacin—Vomiting—Methotrexate—colon cancer	0.000289	0.000761	CcSEcCtD
Niacin—Rash—Methotrexate—colon cancer	0.000287	0.000755	CcSEcCtD
Niacin—Dermatitis—Methotrexate—colon cancer	0.000287	0.000754	CcSEcCtD
Niacin—Headache—Methotrexate—colon cancer	0.000285	0.00075	CcSEcCtD
Niacin—QPRT—Metabolism—ABCB1—colon cancer	0.000285	0.0042	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000281	0.00415	CbGpPWpGaD
Niacin—QPRT—Metabolism—TYMS—colon cancer	0.000279	0.00413	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000276	0.00408	CbGpPWpGaD
Niacin—Nausea—Methotrexate—colon cancer	0.00027	0.000711	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.00027	0.00399	CbGpPWpGaD
Niacin—QPRT—Disease—FGFR3—colon cancer	0.000267	0.00394	CbGpPWpGaD
Niacin—NNMT—Metabolism—ABCB1—colon cancer	0.000265	0.00391	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ODC1—colon cancer	0.000264	0.0039	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CHST5—colon cancer	0.000264	0.0039	CbGpPWpGaD
Niacin—NNMT—Metabolism—TYMS—colon cancer	0.00026	0.00384	CbGpPWpGaD
Niacin—QPRT—Disease—APC—colon cancer	0.000245	0.00362	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.000233	0.00344	CbGpPWpGaD
Niacin—QPRT—Disease—BRAF—colon cancer	0.00023	0.0034	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000214	0.00316	CbGpPWpGaD
Niacin—QPRT—Metabolism—PPARG—colon cancer	0.000198	0.00293	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.000198	0.00292	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—colon cancer	0.000186	0.00275	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—colon cancer	0.000184	0.00272	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000168	0.00248	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—colon cancer	0.000166	0.00246	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGFR3—colon cancer	0.000163	0.00241	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1A—colon cancer	0.000163	0.0024	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—colon cancer	0.000156	0.0023	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGFR3—colon cancer	0.000155	0.00229	CbGpPWpGaD
Niacin—QPRT—Disease—EP300—colon cancer	0.000155	0.00229	CbGpPWpGaD
Niacin—QPRT—Disease—SRC—colon cancer	0.00015	0.00222	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—colon cancer	0.00015	0.00222	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—colon cancer	0.00015	0.00222	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000149	0.0022	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—EP300—colon cancer	0.000145	0.00214	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—colon cancer	0.000145	0.00214	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—colon cancer	0.000145	0.00214	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—colon cancer	0.000142	0.0021	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—colon cancer	0.000142	0.0021	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SRC—colon cancer	0.000141	0.00208	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—colon cancer	0.000141	0.00208	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—colon cancer	0.000137	0.00203	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—colon cancer	0.000137	0.00202	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—colon cancer	0.000136	0.002	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—colon cancer	0.000135	0.00199	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—colon cancer	0.000134	0.00199	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—colon cancer	0.000134	0.00197	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—colon cancer	0.000132	0.00195	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—colon cancer	0.000131	0.00193	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—colon cancer	0.00013	0.00191	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—colon cancer	0.000129	0.00191	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—colon cancer	0.000129	0.00191	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—colon cancer	0.000129	0.00191	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000128	0.00189	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMS—colon cancer	0.000127	0.00187	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—colon cancer	0.000126	0.00186	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—colon cancer	0.000125	0.00184	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—colon cancer	0.000124	0.00183	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—colon cancer	0.000122	0.00181	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA7—colon cancer	0.000121	0.00179	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—colon cancer	0.00012	0.00178	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—colon cancer	0.000119	0.00175	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—colon cancer	0.000117	0.00173	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—colon cancer	0.000114	0.00169	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—colon cancer	0.000112	0.00166	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—colon cancer	0.00011	0.00162	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—colon cancer	0.000107	0.00159	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—colon cancer	0.000107	0.00158	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—colon cancer	0.000106	0.00156	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—colon cancer	0.000106	0.00156	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—colon cancer	0.000104	0.00154	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—colon cancer	0.000104	0.00153	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—colon cancer	0.000103	0.00152	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—colon cancer	0.000102	0.0015	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—colon cancer	0.000101	0.00149	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—colon cancer	0.0001	0.00148	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—colon cancer	9.95e-05	0.00147	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—colon cancer	9.93e-05	0.00147	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—colon cancer	9.75e-05	0.00144	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—colon cancer	9.68e-05	0.00143	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—colon cancer	9.65e-05	0.00143	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—colon cancer	9.58e-05	0.00142	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—colon cancer	9.47e-05	0.0014	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—colon cancer	9.43e-05	0.00139	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—colon cancer	9.35e-05	0.00138	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—colon cancer	9.21e-05	0.00136	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—colon cancer	9.18e-05	0.00136	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—colon cancer	8.99e-05	0.00133	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—colon cancer	8.97e-05	0.00133	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—colon cancer	8.97e-05	0.00132	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—colon cancer	8.91e-05	0.00132	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—colon cancer	8.86e-05	0.00131	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—colon cancer	8.76e-05	0.0013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—colon cancer	8.73e-05	0.00129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—colon cancer	8.5e-05	0.00126	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—colon cancer	8.4e-05	0.00124	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—colon cancer	8.25e-05	0.00122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—colon cancer	8.23e-05	0.00122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—colon cancer	8.07e-05	0.00119	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—colon cancer	7.83e-05	0.00116	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—colon cancer	7.83e-05	0.00116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—colon cancer	7.82e-05	0.00116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—colon cancer	7.8e-05	0.00115	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—colon cancer	7.65e-05	0.00113	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—colon cancer	7.62e-05	0.00113	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—colon cancer	7.62e-05	0.00113	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—colon cancer	7.42e-05	0.0011	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ODC1—colon cancer	7.35e-05	0.00109	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CHST5—colon cancer	7.35e-05	0.00109	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—colon cancer	7.33e-05	0.00108	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—colon cancer	7.28e-05	0.00108	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—colon cancer	7.23e-05	0.00107	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—colon cancer	7.07e-05	0.00104	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—colon cancer	7e-05	0.00103	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—colon cancer	6.98e-05	0.00103	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—colon cancer	6.85e-05	0.00101	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—colon cancer	6.81e-05	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—colon cancer	6.77e-05	0.001	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—colon cancer	6.64e-05	0.000981	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—colon cancer	6.48e-05	0.000957	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—colon cancer	6.42e-05	0.000949	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—colon cancer	6.31e-05	0.000932	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—colon cancer	6.14e-05	0.000908	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—colon cancer	5.88e-05	0.000869	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—colon cancer	5.79e-05	0.000856	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—colon cancer	5.72e-05	0.000845	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—colon cancer	5.6e-05	0.000828	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—colon cancer	5.42e-05	0.000801	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—colon cancer	5.36e-05	0.000792	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—colon cancer	4.85e-05	0.000717	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—colon cancer	4.73e-05	0.000699	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—colon cancer	4.35e-05	0.000643	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—colon cancer	3.82e-05	0.000564	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—colon cancer	3.55e-05	0.000525	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—colon cancer	3.18e-05	0.000469	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—colon cancer	2.35e-05	0.000347	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—colon cancer	1.94e-05	0.000287	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—colon cancer	1.92e-05	0.000284	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—colon cancer	1.91e-05	0.000282	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—colon cancer	1.35e-05	0.0002	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—colon cancer	1.06e-05	0.000157	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—colon cancer	8.85e-06	0.000131	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—colon cancer	6.54e-06	9.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—colon cancer	5.35e-06	7.9e-05	CbGpPWpGaD
